There were no significant differences between the two cohorts with respect to sex, body mass index, anthropometric parameters, presence of dyslipidemia, hypertension, stable coronary artery disease, smoking, abdominal obesity, systolic and diastolic blood pressure, left ventricular dimensions, LVEF, LVMI, E/e′, GLS, eGFR, lipid profile, glucose levels, TNF-alpha, NT-proBNP, adropin, visfatin, fetuin-A, or hs-TrT. This evidence concerns the gene ENHO and hypertensive disorder.